|Articles|August 10, 2015

CRF Health Unveils TrialMax ConMed™ for Oncology Trials

The identification of concomitant medication poses specific challenges in oncology data reporting.

CRF Health, a global provider of electronic Clinical  Outcome Assessment (eCOA) solutions introduced a complete TrialMax® eCOA solution specifically for oncology clinical trials. The identification of concomitant medication poses specific challenges in oncology data reporting. To address this, CRF Health has incorporated its new TrialMax ConMed™ solution into the platform, allowing patients to report concomitant medication taken during a trial in real-time.
 
 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.